Suresh Ramalingam, MD, FASCO; Winship Cancer Institute Emory University 5Live #ASCO20
5:27
Key insights on Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1.
Lung Cancer
Suresh Ramalingam, MD, FASCO; Winship Cancer Institute Emory University 5Live #ASCO20
Key insights on Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1.
Lung Cancer Similar Videos
Similar Videos
-
Antibody-Drug Conjugates in Lung Cancer_Benjamin Levy, MD
50:57
-
Addressing Disparities in Cancer Care: Incorporating Precision Medicine for Minority Populations_Narjust Duma, MD_Nathaniel Evans III, MD
44:14
-
Narjust Duma, MD; University of Wisconsin-Madison, University of Wisconsin Carbone Cancer Center; 5Live; #IASLC21
5:10
